Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.81 USD | 0.00% | -1.22% | -23.74% |
Evolution of the average Target Price on Pliant Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Pliant Therapeutics, Inc.
Oppenheimer | |
RBC Capital Markets | |
HC Wainwright | |
Canaccord Genuity | |
Cantor Fitzgerald | |
Baird | |
Citigroup | |
JPMorgan Chase | |
SVB Securities LLC | |
Needham & Co. | |
Stifel Nicolaus | |
Piper Sandler | |
Brigantine Advisors |
EPS Revisions
- Stock Market
- Equities
- PLRX Stock
- Consensus Pliant Therapeutics, Inc.